Tyler Mane built his screen career playing characters who are hard to forget. Fans know the former professional wrestler as Sabretooth in "X-Men," Ajax in "Troy," and Michael Myers in the "Halloween" films. Now, Mane is facing something far more personal than any movie role.
The actor, now 59, has revealed that he was diagnosed with male breast cancer after discovering a hard lump on the left side of his chest. The cancer was caught at Stage 1, and Mane credits his wife, Renae Geerlings, with pushing him to take the lump seriously when he thought it was harmless.
Tyler Mane Almost Dismissed the Lump
Mane / IG / Mane noticed the lump after losing body fat during a push to improve his health. He initially believed the growth might disappear on its own.
The actor had dealt with fatty tissue before, so breast cancer was hardly the first possibility that came to mind. His wife had a different reaction. Geerlings urged Mane to have the lump checked instead of waiting for it to go away. That persistence became especially important because Mane's first medical visit did not immediately raise major concerns about cancer.
Mane has said his primary care doctor was also fairly dismissive about the lump. He was eventually directed to a dermatologist, who recognized that the mass was located in breast tissue and referred him to a surgeon. The surgeon still believed the growth was probably benign.
The "Halloween" actor decided to have the lump removed rather than simply leave it alone. Surgery took place on April 1, and the pathology report brought the news that nobody expected. The mass was invasive ductal carcinoma, commonly known as IDC.
The removed tumor measured 28 millimeters, according to Mane's later account of his diagnosis. Further testing showed that the cancer had not spread to the three lymph nodes removed from his left armpit. Doctors classified his breast cancer as Stage 1.
That early diagnosis is one reason Mane has been so vocal about his wife's role. Had Geerlings accepted his original explanation and stopped pushing the issue, the cancer might have remained unnoticed for longer. Mane has openly credited her persistence with saving his life.
A Rare Cancer Diagnosis Mane Nearly Kept Secret
Mane / IG / Breast cancer is strongly associated with women, but men have breast tissue and can develop the disease.
The National Cancer Institute says fewer than 1 in 100 breast cancers in the United States occur in men. Most male breast cancers begin in the milk ducts.
Invasive ductal carcinoma is also the most common form found in male patients. The American Cancer Society says at least eight out of every 10 male breast cancers are invasive ductal carcinomas. These cancers begin in duct cells before growing into surrounding breast tissue.
Mane admitted that his first instinct was to keep the diagnosis private. He felt embarrassed because breast cancer is so commonly viewed as a women's disease. He later changed his mind after learning how silence around male breast cancer can contribute to delayed diagnoses.
His decision to talk carries weight because male breast cancer remains uncommon and poorly understood by many people. The American Cancer Society estimates that around 2,670 men in the United States will be diagnosed with invasive breast cancer during 2026. About 530 men are expected to die from it.
How Common is the Risk?
The average man's lifetime risk of developing breast cancer is about 1 in 755. Risk also rises with age, and the average age at diagnosis falls between 60 and 70. Mane's experience shows why a rare disease should not automatically be treated as an impossible one.
The former professional wrestler also learned that he carries a BRCA2 gene mutation. Harmful changes in BRCA2 can raise the risk of several cancers, including male breast cancer. The finding also has possible implications for biological relatives because harmful BRCA gene changes can be inherited.
For men with a harmful BRCA2 change, the breast cancer risk is considerably higher than it is for men in the general population. The National Cancer Institute estimates that about 1.8% to 7.1% of male BRCA2 carriers develop breast cancer by age 70.
The genetic result gave Mane another reason to discuss his health publicly. It also gave his family information that could matter beyond his own treatment. Genetic findings can help relatives talk with medical professionals about their personal risks and whether testing makes sense.
